CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Magnetic Resonance Guided Focused Ultrasoundprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00159328
NCT00159328Phase 4Completed
CompareCT.gov

Phase 4 Study of Magnetic Resonance Guided Focused Ultrasound Surgery Following Gonadotrophin Releasing Hormone Agonist Treatment for Symptomatic Uterine Fibroids

Imperial College London·interventional·Posted Sep 12, 2005·Updated Aug 13, 2008

In Brief

A Phase 4 clinical trial evaluating Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine whether ablation of uterine fibroids with MR guided focused ultrasound following 3 months pre-treatment with Gonadotrophin releasing analogues will allow the effective use of this therapy in women with larger fibroids.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Fibroids
CountriesUnited Kingdom
CollaboratorsInSightec-TxSonics

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartMar 1, 2003
Study CompletionDec 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Magnetic Resonance Guided Focused Ultrasoundprocedure